{"meta":{"query_hash":"ac2bfcb93da8","filters":{"venue":"Experimental Hematology and Oncology"},"cohort_total":26,"direct_labels_cover":0,"predictions_cover":26,"exported":26,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ac2bfcb93da8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Experimental+Hematology+and+Oncology"},"results":[{"id":"W2096261897","doi":"10.1186/2162-3619-2-32","title":"Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Sunitinib; Medicine; Everolimus; Neuroendocrine tumors; Pancreatic neuroendocrine tumor; Internal medicine; Hematology; Oncology; Matching (statistics); Pathology; Cancer","score_opus":0.0363331061368733,"score_gpt":0.37481042835918443,"score_spread":0.33847732222231114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096261897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92583084,0.028237993,0.024897022,0.0008538613,0.001682526,0.004707941,0.0068802154,0.00019425065,0.0067153387],"genre_scores_gemma":[0.9845502,0.0015487617,0.007553304,0.0003652647,0.00015828434,0.0029745682,0.0014939292,0.00002752044,0.0013281112],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9749658,0.019411983,0.0017416772,0.0019371624,0.0013690033,0.00057433516],"domain_scores_gemma":[0.98664814,0.008904803,0.0021886036,0.0014842682,0.00051153026,0.00026263078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016183235,0.0016088662,0.0032970386,0.0010466658,0.00032620307,0.0012936256,0.0013407915,0.0013991419,0.007952735],"category_scores_gemma":[0.02866583,0.00052606827,0.010190342,0.0009947395,0.00059939874,0.0010533651,0.0017778752,0.0017764821,0.00044152286],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57048756,0.0015919878,0.05670845,0.012818305,0.2683373,0.00026490702,0.0004351165,0.008875771,0.003058347,0.0046256357,0.0027440046,0.070052594],"study_design_scores_gemma":[0.24889539,0.09471053,0.15280008,0.0018764689,0.4260879,0.00088435545,0.0005735733,0.033519182,0.00625455,0.016423024,0.01760413,0.00037086202],"about_ca_topic_score_codex":0.0011169417,"about_ca_topic_score_gemma":0.0011633475,"teacher_disagreement_score":0.016183235,"about_ca_system_score_codex":0.0007817955,"about_ca_system_score_gemma":0.00078618346,"threshold_uncertainty_score":0.08558619},"labels":[],"label_agreement":null},{"id":"W2099215382","doi":"10.1186/2162-3619-2-20","title":"Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Cancer Society Research Institute","keywords":"Cytarabine; Medicine; Myeloid leukemia; Leukemia; Pharmacology; Myeloid; Internal medicine; Oncology","score_opus":0.021737496306857704,"score_gpt":0.3558260449127454,"score_spread":0.33408854860588766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099215382","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25072673,0.6435237,0.060179655,0.00342018,0.0007582492,0.00072841014,0.0012368939,0.0005494444,0.038876776],"genre_scores_gemma":[0.65000397,0.2767295,0.06217353,0.0012052201,0.00042434954,0.0004642611,0.0014185947,0.00013478787,0.0074458593],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997392,0.000068777925,0.000023532997,0.000036601712,0.000110854744,0.000021052416],"domain_scores_gemma":[0.99994004,0.000010026398,0.000019552353,0.0000024039223,0.00001932296,0.000008619079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003281022,0.00042546986,0.00038487389,0.00037661704,0.00012521578,0.00049854536,0.00027306093,0.00023448882,0.0014887091],"category_scores_gemma":[0.00028993134,0.00012626623,0.00025109772,0.00046299535,0.00009074129,0.00028489198,0.0002144358,0.00061930955,0.0006150101],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010762151,0.0005617764,0.0026219804,0.003557515,0.00015585558,0.00030062787,0.00010789718,0.014913889,0.35560435,0.003671255,0.008670411,0.6087582],"study_design_scores_gemma":[0.00055735436,0.0053675645,0.029080894,0.0009032246,0.0005857083,0.003577873,0.00015036037,0.015706306,0.21198945,0.0036449765,0.7283224,0.00011397804],"about_ca_topic_score_codex":0.0007240536,"about_ca_topic_score_gemma":0.0013291738,"teacher_disagreement_score":0.0014887091,"about_ca_system_score_codex":0.00040831743,"about_ca_system_score_gemma":0.00042196992,"threshold_uncertainty_score":0.004980266},"labels":[],"label_agreement":null},{"id":"W2103118894","doi":"10.1186/2162-3619-1-12","title":"Expansion of hematopoietic stem cells for transplantation: current perspectives","year":2012,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Haematopoiesis; Stem cell; Hematology; Transplantation; Medicine; Bone marrow; Hematopoietic stem cell transplantation; Immunology; Hematopoietic stem cell; Genetic enhancement; Cancer research; Biology; Internal medicine; Gene; Cell biology; Genetics","score_opus":0.03408724952600803,"score_gpt":0.35048768365288413,"score_spread":0.31640043412687613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103118894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017760699,0.9725604,0.005758477,0.013748587,0.0008299089,0.000026324506,0.00007069799,0.00007034558,0.0051591634],"genre_scores_gemma":[0.012123612,0.9748674,0.00592159,0.002699529,0.0025501167,0.000072748386,0.0001675021,0.000023712306,0.001573792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930525,0.00016272598,0.000081328275,0.00009884741,0.00028748042,0.00006434191],"domain_scores_gemma":[0.99735045,0.0014044687,0.00017557491,0.000113763104,0.00061794766,0.00033786483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005847435,0.0011175477,0.0011317988,0.0010324041,0.00050860114,0.0032405083,0.001600632,0.0029869627,0.008804182],"category_scores_gemma":[0.0025511964,0.00036235008,0.000567893,0.0011884583,0.0022750976,0.005513325,0.000937407,0.0037950105,0.003181],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000583157,0.00051268534,0.0009688194,0.006261689,0.000074955395,0.00039274775,0.00022851267,0.0015979287,0.014106346,0.03446489,0.048167698,0.8926406],"study_design_scores_gemma":[0.00021061876,0.001147275,0.0015708173,0.003248503,0.00017775841,0.0016680576,0.0004621003,0.0018777815,0.010136081,0.040217936,0.93920255,0.00008044555],"about_ca_topic_score_codex":0.0006242388,"about_ca_topic_score_gemma":0.0013528598,"teacher_disagreement_score":0.008804182,"about_ca_system_score_codex":0.0011075004,"about_ca_system_score_gemma":0.002269798,"threshold_uncertainty_score":0.030924559},"labels":[],"label_agreement":null},{"id":"W2110901075","doi":"10.1186/2162-3619-3-26","title":"Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial","year":2014,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck","keywords":"Erlotinib; Medicine; Internal medicine; Randomized controlled trial; Oncology; Lung cancer; Antibody; Erlotinib Hydrochloride; Cancer; Immunology; Epidermal growth factor receptor","score_opus":0.007392533454674619,"score_gpt":0.30671340821407567,"score_spread":0.29932087475940106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110901075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157035,0.004502111,0.00037158307,0.0005516806,0.00019336156,0.0012731557,0.0005264748,0.000044619675,0.0009666534],"genre_scores_gemma":[0.99331915,0.0019693037,0.00076163496,0.00074512284,0.000248087,0.001154332,0.0010690517,0.000011385357,0.0007219117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99912053,0.0004889713,0.00007312802,0.00015039739,0.00006523286,0.00010173426],"domain_scores_gemma":[0.99878556,0.00026964993,0.0003122492,0.00007726543,0.00007783208,0.0004773958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027022709,0.0016334008,0.0020593286,0.00037653898,0.00040214846,0.0010693683,0.00090522005,0.001342989,0.0029699989],"category_scores_gemma":[0.0015391917,0.0005576326,0.0020355638,0.00044300323,0.0010576431,0.0008401685,0.00037742034,0.002507354,0.0005782287],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9551356,0.008923055,0.003529128,0.0005252215,0.0014574184,0.00008328996,0.00006767888,0.0005258656,0.0050624115,0.00006851049,0.00075586507,0.02386604],"study_design_scores_gemma":[0.8951924,0.09848228,0.003595015,0.00002383111,0.0007562562,0.000091572474,0.00001673951,0.00046959097,0.00058663083,0.00006580256,0.000707317,0.00001250214],"about_ca_topic_score_codex":0.000543659,"about_ca_topic_score_gemma":0.0013481433,"teacher_disagreement_score":0.0029699989,"about_ca_system_score_codex":0.0010684237,"about_ca_system_score_gemma":0.0012329855,"threshold_uncertainty_score":0.014291108},"labels":[],"label_agreement":null},{"id":"W2150942773","doi":"10.1186/2162-3619-2-26","title":"ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; National Institutes of Health; Children's Hospital Foundation; Royal Children's Hospital Foundation; Terry Fox Research Institute; University of Toronto; Pediatric Brain Tumor Foundation","keywords":"Medulloblastoma; Cancer research; Biology; Abcg2; ATP-binding cassette transporter; Apoptosis; In vivo; Cancer stem cell; Stem cell; Glioma; Transporter; Immunology; Cell biology; Genetics; Gene","score_opus":0.007394195033527149,"score_gpt":0.2774493438181646,"score_spread":0.27005514878463743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150942773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858785,0.0006247849,0.00020181837,0.000021960068,0.0000013080911,0.00000756623,0.00034460722,0.000010145661,0.00019995564],"genre_scores_gemma":[0.99832565,0.0004949434,0.00032292423,0.000010639891,0.0000033763154,0.000011914409,0.000713422,0.000005659843,0.00011149771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998815,0.0000114880295,0.000010747923,0.000038975595,0.000032642754,0.000024684305],"domain_scores_gemma":[0.9998128,0.000023705996,0.00010979609,0.000008730601,0.00002126492,0.00002378462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118719356,0.00018405325,0.0003204177,0.0005278456,0.00020218958,0.00026635543,0.00018366319,0.00019611213,0.0008349287],"category_scores_gemma":[0.00029813946,0.00010946588,0.00019131872,0.0007510698,0.00018898981,0.000151214,0.00016120682,0.0002586828,0.00016609865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001182126,0.00007154192,0.86853606,0.00013711058,0.00008778048,0.0023382436,0.000261368,0.00045454068,0.109664366,0.00012682495,0.0003813374,0.016758753],"study_design_scores_gemma":[0.000012974768,0.00017485127,0.9821692,0.0000072999496,0.00007515255,0.006768708,0.000167608,0.00041288795,0.0088947425,0.00006998591,0.0012417093,0.000004853571],"about_ca_topic_score_codex":0.0030417268,"about_ca_topic_score_gemma":0.0029044899,"teacher_disagreement_score":0.0030417268,"about_ca_system_score_codex":0.000503066,"about_ca_system_score_gemma":0.00024346997,"threshold_uncertainty_score":0.0060480237},"labels":[],"label_agreement":null},{"id":"W2287099773","doi":"10.1186/s40164-016-0035-4","title":"Nucleotide excision repair deficiency in melanoma in response to UVA","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council; Multiple Sclerosis Australia; Cancer Institute NSW; Canadian Institutes of Health Research; Cure Cancer Australia Foundation; Cancer Australia","keywords":"Nucleotide excision repair; Melanoma; Cancer research; Genetics; Medicine; Biology; DNA repair; DNA","score_opus":0.018024735610118747,"score_gpt":0.31898564663437073,"score_spread":0.300960911024252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287099773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682355,0.0016114578,0.0005344816,0.00004672302,0.0000213497,0.000028332026,0.0002893976,0.000044779943,0.0005999856],"genre_scores_gemma":[0.9966444,0.00071501493,0.00056094077,0.000028717752,0.000006283829,0.000029824994,0.00032938557,0.000010396835,0.0016750686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998777,0.000019958798,0.000015050826,0.00003653713,0.00003360371,0.000017158643],"domain_scores_gemma":[0.99980456,0.000029342744,0.00006690359,0.000020815278,0.000022344613,0.000056138357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014207633,0.00028987494,0.00029217536,0.00039240034,0.00021295293,0.00027215513,0.00014548087,0.00046169915,0.0029981534],"category_scores_gemma":[0.00016605161,0.00019272376,0.0002704204,0.00023402668,0.00017200677,0.00013569134,0.00019201041,0.000474049,0.0006324867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026216556,0.00007789388,0.004091933,0.00007376167,0.000016844575,0.000923568,0.000029644772,0.000025879945,0.9931524,0.000023693798,0.000049803377,0.0012725447],"study_design_scores_gemma":[0.00007025786,0.0032242746,0.3667329,0.00006855223,0.00016491581,0.027769892,0.00035062726,0.0008498904,0.59447265,0.0002819966,0.005989451,0.000024725212],"about_ca_topic_score_codex":0.00024520062,"about_ca_topic_score_gemma":0.00037230906,"teacher_disagreement_score":0.0029981534,"about_ca_system_score_codex":0.00017047554,"about_ca_system_score_gemma":0.00010105908,"threshold_uncertainty_score":0.010029793},"labels":[],"label_agreement":null},{"id":"W2300107978","doi":"10.1186/s40164-016-0037-2","title":"Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fusion transcript; Sanger sequencing; Exon; Breakpoint; Fusion gene; Myeloid leukemia; Chromosomal translocation; Myeloid sarcoma; Karyotype; Myeloid; Biology; Cancer research; Cytogenetics; Leukemia; Molecular biology; Medicine; Pathology; Gene; Genetics; DNA sequencing; Chromosome","score_opus":0.018831109176002888,"score_gpt":0.3061671611899829,"score_spread":0.28733605201398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300107978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962239,0.0011064267,0.00067665987,0.00020181968,0.000027967815,0.000016616304,0.00017521295,0.000048632697,0.0015227085],"genre_scores_gemma":[0.99875724,0.00043646758,0.00027183487,0.000048739075,0.00006006981,0.0000063309976,0.000116027564,0.0000081254875,0.00029508353],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99979275,0.000019211015,0.000028215294,0.000060813993,0.00003957393,0.000059407732],"domain_scores_gemma":[0.9984144,0.00046503934,0.00063929136,0.00007085355,0.00007591175,0.00033452015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023446465,0.0005354571,0.00033997968,0.0011249465,0.00044623137,0.00035899936,0.00036009742,0.0012410365,0.003209104],"category_scores_gemma":[0.0012629126,0.00025563227,0.0002260862,0.00091458875,0.00070294307,0.0005811011,0.00045553927,0.00056211086,0.0007132952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034275622,0.000067302244,0.37227488,0.00012905178,0.000030689487,0.596124,0.0006464329,0.00024908117,0.022527732,0.00043183748,0.0005156086,0.0066606426],"study_design_scores_gemma":[0.000010599289,0.00016310065,0.18295763,0.0000218705,0.0000386436,0.81057864,0.00039175,0.00027945027,0.0034580887,0.00029902742,0.0017812857,0.000019898434],"about_ca_topic_score_codex":0.0005461489,"about_ca_topic_score_gemma":0.0005464017,"teacher_disagreement_score":0.003209104,"about_ca_system_score_codex":0.00023704329,"about_ca_system_score_gemma":0.00022064422,"threshold_uncertainty_score":0.010735571},"labels":[],"label_agreement":null},{"id":"W2399733579","doi":"10.1186/s40164-016-0043-4","title":"Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; National Institute for Health and Care Research","keywords":"Medicine; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Etiology; Internal medicine; Logistic regression; Myelofibrosis; Disease; Denial; Hematology; Medical record; Bone marrow","score_opus":0.026269811310591206,"score_gpt":0.3451570595030722,"score_spread":0.318887248192481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399733579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990957,0.00016046003,0.00005009587,0.00006128744,0.0000068649897,0.000019470244,0.00008374172,0.0000014986531,0.00052084686],"genre_scores_gemma":[0.9996093,0.00009748444,0.00005160348,0.000047611087,0.00001215565,0.000015735022,0.000075170465,8.8378965e-7,0.00009004898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984584,0.0007003354,0.00012569742,0.00025380123,0.00030048893,0.00016123021],"domain_scores_gemma":[0.9968925,0.0010639903,0.0012177165,0.00017332323,0.00023493789,0.0004175423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016630058,0.00026460493,0.00032031783,0.0010278338,0.0011318091,0.0011349975,0.00038478387,0.0006801455,0.002490155],"category_scores_gemma":[0.005596253,0.0003495089,0.00027071184,0.0011014023,0.00051818124,0.00063956773,0.0007355872,0.000748353,0.00025343747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013604751,0.00022459855,0.99522746,0.000021151936,0.000024873492,0.0011634288,0.0018864304,0.000013393313,0.00019268124,0.00004006394,0.0001368345,0.00093319954],"study_design_scores_gemma":[0.000035668276,0.0005722563,0.9881671,0.00002840354,0.00004563513,0.006272219,0.0038864345,0.00018450546,0.00009805293,0.000040871153,0.00065371895,0.000015178922],"about_ca_topic_score_codex":0.004633262,"about_ca_topic_score_gemma":0.0035138284,"teacher_disagreement_score":0.004633262,"about_ca_system_score_codex":0.00043979302,"about_ca_system_score_gemma":0.00032319484,"threshold_uncertainty_score":0.0092125535},"labels":[],"label_agreement":null},{"id":"W2672210777","doi":"10.1186/s40164-017-0078-1","title":"Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Instituto UNIEMP; Universidade Estadual de Campinas","keywords":"Medicine; Methotrexate; Internal medicine; Rheumatoid arthritis; Adverse effect; Gastroenterology; Inflammatory bowel disease; Disease","score_opus":0.018065707391931377,"score_gpt":0.3064347565468245,"score_spread":0.28836904915489314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2672210777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695516,0.0016657558,0.0002000686,0.0001175841,0.000052419076,0.00061105087,0.00006201461,0.0000124706685,0.00032351285],"genre_scores_gemma":[0.99551517,0.0018932541,0.0008169253,0.00027105017,0.00023923401,0.0006301567,0.00016658101,0.0000050404724,0.00046260547],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991393,0.0005111395,0.00007276861,0.000074938325,0.00008080156,0.00012110748],"domain_scores_gemma":[0.99881953,0.00039578244,0.00015910297,0.00011023957,0.00009246109,0.00042280072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019508046,0.00066414534,0.0016416007,0.00042615546,0.00046857836,0.0004762434,0.00055853155,0.0007877564,0.0017023432],"category_scores_gemma":[0.0012332897,0.00027492267,0.0010463827,0.00043582017,0.0008856753,0.00044625727,0.00034439584,0.001340683,0.00034024683],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4242176,0.27665773,0.025826836,0.0019788858,0.0014410912,0.0022187193,0.0015508682,0.0007836934,0.1330496,0.00026291414,0.00092819874,0.1310839],"study_design_scores_gemma":[0.04243636,0.9374367,0.017124895,0.000021574633,0.0002892361,0.00023864496,0.00007271045,0.00013123076,0.0015742511,0.00003270847,0.00062914606,0.000012458619],"about_ca_topic_score_codex":0.00066384376,"about_ca_topic_score_gemma":0.0013890121,"teacher_disagreement_score":0.0019508046,"about_ca_system_score_codex":0.00027054752,"about_ca_system_score_gemma":0.00077076716,"threshold_uncertainty_score":0.010316968},"labels":[],"label_agreement":null},{"id":"W2735791343","doi":"10.1186/s40164-017-0080-7","title":"Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature","year":2017,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Medicine; Apixaban; Heparin-induced thrombocytopenia; Heparin; Thrombosis; Platelet factor 4; Platelet activation; Anticoagulant; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Surgery; Internal medicine; Anesthesia; Platelet; Rivaroxaban; Warfarin; Dabigatran; Thrombin; Atrial fibrillation","score_opus":0.07314740565924846,"score_gpt":0.4247223183356783,"score_spread":0.3515749126764298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735791343","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059404366,0.9189412,0.0040997416,0.0048213485,0.001907195,0.00014695225,0.00022649937,0.00017015575,0.010282622],"genre_scores_gemma":[0.3759023,0.6053462,0.0039841416,0.0044347215,0.0072406447,0.00011625953,0.00047352916,0.000049366354,0.0024528468],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99930036,0.0001153815,0.00023724607,0.0001145251,0.00013856006,0.00009382195],"domain_scores_gemma":[0.9992797,0.00024421845,0.00027512928,0.0000395586,0.00008003992,0.000081290054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037243188,0.0014467584,0.0011479985,0.0034571162,0.00091983017,0.0014403831,0.0016585807,0.003111785,0.0018524273],"category_scores_gemma":[0.0014734265,0.00043539892,0.0008256111,0.0029485,0.0010242683,0.0020923365,0.00066143577,0.0015858314,0.00077448454],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047429883,0.0001042698,0.0074862777,0.0030367954,0.00012651637,0.9300858,0.00034754444,0.00022513322,0.0013109812,0.0005979633,0.007505268,0.04912601],"study_design_scores_gemma":[0.000012137862,0.0000397621,0.0022874242,0.0006990602,0.00010427207,0.9826717,0.00025605748,0.00018128144,0.00032402086,0.0002631609,0.013143293,0.000017890488],"about_ca_topic_score_codex":0.00084241753,"about_ca_topic_score_gemma":0.0009905985,"teacher_disagreement_score":0.0034571162,"about_ca_system_score_codex":0.00055207487,"about_ca_system_score_gemma":0.000878255,"threshold_uncertainty_score":0.0061969757},"labels":[],"label_agreement":null},{"id":"W2805371265","doi":"10.1186/s40164-018-0098-5","title":"Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report","year":2018,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Aplastic anemia; Neutropenia; Oncology; Cancer; Bone marrow; Immunotherapy; Chemotherapy","score_opus":0.012702777517378966,"score_gpt":0.3125096891512824,"score_spread":0.29980691163390344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805371265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608233,0.014850628,0.0041742846,0.0076073143,0.0007413101,0.00034900755,0.00043951822,0.00034084462,0.010673924],"genre_scores_gemma":[0.9912725,0.00278966,0.0012710686,0.001739572,0.001430677,0.00003277881,0.00012105636,0.000036912566,0.0013058111],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990754,0.00012693975,0.00012899583,0.00026721548,0.00012977293,0.00027158792],"domain_scores_gemma":[0.9982101,0.0004464637,0.00042612164,0.00013274915,0.00012358994,0.00066099357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046168503,0.0019685577,0.001682643,0.003024759,0.003077616,0.0022784167,0.0012185449,0.0063702916,0.0021624619],"category_scores_gemma":[0.0028193588,0.0014958632,0.0016595133,0.0015200785,0.0013877229,0.0021547547,0.0016602001,0.0043544755,0.0007998305],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022590772,0.0000354435,0.0033864516,0.000024433159,0.000010077361,0.9951988,0.00012925608,0.00003587313,0.00029456546,0.000065377666,0.00024091192,0.00055623264],"study_design_scores_gemma":[0.00000767201,0.00004244107,0.0016317363,0.000011065134,0.000010234132,0.9976503,0.00006965763,0.000120884215,0.000109430075,0.000060594157,0.0002799076,0.000006078976],"about_ca_topic_score_codex":0.0030599062,"about_ca_topic_score_gemma":0.0029994864,"teacher_disagreement_score":0.0063702916,"about_ca_system_score_codex":0.001502355,"about_ca_system_score_gemma":0.0010028105,"threshold_uncertainty_score":0.010900378},"labels":[],"label_agreement":null},{"id":"W2890474078","doi":"10.1186/s40164-018-0114-9","title":"Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy","year":2018,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hydro One (Canada); Apotex (Canada)","funders":"","keywords":"Biosimilar; Pegfilgrastim; Medicine; Breast cancer; Equivalence (formal languages); Oncology; Internal medicine; Pharmacology; Medical physics; Filgrastim; Cancer; Granulocyte colony-stimulating factor; Chemotherapy; Mathematics","score_opus":0.057752972183594625,"score_gpt":0.41614632596557355,"score_spread":0.3583933537819789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890474078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859232,0.0008212566,0.0016105836,0.00018688667,0.00030990428,0.009468161,0.00037929477,0.000033050874,0.0012675931],"genre_scores_gemma":[0.9886043,0.00036930304,0.0028303326,0.0004051431,0.00019267453,0.0062396494,0.0003612563,0.00001285804,0.0009843978],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952586,0.0026159512,0.00039770303,0.00061327,0.00073588185,0.00037866517],"domain_scores_gemma":[0.99548596,0.001505218,0.0010845935,0.00057424663,0.0006153101,0.0007346695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008245081,0.00089153904,0.0027323775,0.0004357778,0.00044406552,0.0010198423,0.00072927045,0.0018989443,0.005601384],"category_scores_gemma":[0.006631491,0.00041864102,0.0021643776,0.0004352601,0.0015013003,0.0009000281,0.00052072224,0.0026665665,0.0008968867],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93117404,0.034615252,0.002380378,0.00037046266,0.00075891585,0.00008273782,0.00016795035,0.00047685552,0.010757016,0.00041560023,0.00053696823,0.018263858],"study_design_scores_gemma":[0.20628919,0.7790297,0.0066478048,0.000035349512,0.00058512145,0.00008901329,0.000056373574,0.0012069396,0.003231733,0.0003445451,0.0024524233,0.000031756925],"about_ca_topic_score_codex":0.0001731757,"about_ca_topic_score_gemma":0.0002351811,"teacher_disagreement_score":0.008245081,"about_ca_system_score_codex":0.0007925346,"about_ca_system_score_gemma":0.0012183157,"threshold_uncertainty_score":0.043604672},"labels":[],"label_agreement":null},{"id":"W3036033661","doi":"10.1186/s40164-020-00170-6","title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","year":2020,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Medical Association","funders":"Department of Education of Guizhou Province; Guizhou Science and Technology Department; National Natural Science Foundation of China","keywords":"Medicine; Leukemia; Incidence (geometry); Myeloid leukemia; Chronic lymphocytic leukemia; Internal medicine; Demography","score_opus":0.12036463846384143,"score_gpt":0.4121852002020398,"score_spread":0.29182056173819837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036033661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46525118,0.04735166,0.002241297,0.0038772759,0.00051386794,0.00016204893,0.46152908,0.00065183424,0.018421853],"genre_scores_gemma":[0.65388757,0.04402221,0.002933813,0.0013873731,0.00048528946,0.0003422944,0.29343662,0.0001388553,0.0033659562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990681,0.000112745714,0.00020922585,0.00019228431,0.0002593776,0.00015821372],"domain_scores_gemma":[0.99807906,0.00012408682,0.000777781,0.000048053498,0.000833746,0.0001373224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063897274,0.00032917966,0.0003879581,0.0030844207,0.00020012583,0.0006883243,0.0003374162,0.00021480702,0.0026442697],"category_scores_gemma":[0.0029480697,0.00018120355,0.0007223581,0.0054136533,0.00020866889,0.0007694649,0.00071719236,0.00067664264,0.0010753343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023086247,0.000026213374,0.85368484,0.001722556,0.00042468545,0.00016680782,0.0005851952,0.0012737102,0.0005249945,0.0013137129,0.075752325,0.064294145],"study_design_scores_gemma":[0.000030310779,0.000056775392,0.90620655,0.00075470074,0.0003448836,0.00074423134,0.0008026916,0.0007066146,0.0005042502,0.00033538928,0.089486934,0.000026713833],"about_ca_topic_score_codex":0.048624102,"about_ca_topic_score_gemma":0.052709643,"teacher_disagreement_score":0.048624102,"about_ca_system_score_codex":0.0016084571,"about_ca_system_score_gemma":0.0017648544,"threshold_uncertainty_score":0.09668213},"labels":[],"label_agreement":null},{"id":"W3119693976","doi":"10.1186/s40164-020-00197-9","title":"AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL","year":2021,"lang":"en","type":"review","venue":"Experimental Hematology and Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"Transcription factor; Lymphoma; Cancer research; Hodgkin lymphoma; Transcription (linguistics); Cell biology; Biology; Chemistry; Genetics; Gene; Immunology","score_opus":0.0726494717260614,"score_gpt":0.3470231436944375,"score_spread":0.2743736719683761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119693976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011906961,0.9987883,0.000097644326,0.000121317695,0.00012430249,0.0000034284571,0.000019915804,0.000006057716,0.00071995775],"genre_scores_gemma":[0.0005962016,0.9984403,0.00014767729,0.00012453216,0.00009480957,0.0000054183415,0.000049826904,0.0000011332565,0.00053996017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989545,0.00001273367,0.000018310167,0.000019341309,0.00004195598,0.000012160127],"domain_scores_gemma":[0.99988866,0.00003950235,0.000022956565,0.0000031262118,0.000032148735,0.000013531682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002760197,0.0007720528,0.0010124737,0.0021332705,0.00024206685,0.0007882561,0.0006433719,0.00069013983,0.002482593],"category_scores_gemma":[0.00031328533,0.00021311542,0.0003517629,0.002213242,0.00030174825,0.0009016374,0.0005102032,0.0014637385,0.002231769],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007144769,0.000051575287,0.00016619565,0.014930296,0.00006866465,0.00019054262,0.000059594215,0.00019310664,0.0030918962,0.0017253964,0.017717462,0.9617338],"study_design_scores_gemma":[0.000018784776,0.000070886046,0.00086293486,0.0025907038,0.00010703729,0.0020075387,0.000054400614,0.000052825537,0.00082493754,0.0011369144,0.99225837,0.000014591184],"about_ca_topic_score_codex":0.00065460865,"about_ca_topic_score_gemma":0.001203466,"teacher_disagreement_score":0.002482593,"about_ca_system_score_codex":0.0004235198,"about_ca_system_score_gemma":0.0006322698,"threshold_uncertainty_score":0.008305073},"labels":[],"label_agreement":null},{"id":"W4220932718","doi":"10.1186/s40164-022-00268-z","title":"Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel","year":2022,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; EVERSANA (Canada)","funders":"Bristol-Myers Squibb; American Society of Hematology","keywords":"Medicine; Oncology; Hazard ratio; Internal medicine; Confidence interval; Cytokine release syndrome; Odds ratio; Chimeric antigen receptor; Immunology; Immunotherapy; Cancer","score_opus":0.07916506812500414,"score_gpt":0.3910096793426737,"score_spread":0.3118446112176696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220932718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223936,0.026200332,0.022766173,0.0009880112,0.0021024414,0.010003606,0.0052188593,0.00025432953,0.010072662],"genre_scores_gemma":[0.98042667,0.0015240207,0.009025177,0.0005799931,0.00023212416,0.0050019515,0.001573855,0.000037063965,0.0015992475],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9729647,0.021895118,0.0015733243,0.0014234366,0.0015524282,0.0005908798],"domain_scores_gemma":[0.9832323,0.010075664,0.0038100989,0.0015369875,0.0008611337,0.0004838544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017897671,0.0013714143,0.0027223998,0.0010465592,0.0003042473,0.0013303821,0.0012190371,0.0012067747,0.008711941],"category_scores_gemma":[0.026100302,0.00040345272,0.007217424,0.0007192649,0.00072861434,0.0008643035,0.0012484399,0.0020754416,0.0005241782],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84743726,0.0017029186,0.009275045,0.0048640305,0.059871875,0.000065743174,0.00021794901,0.0029319956,0.002485525,0.0022023516,0.0018419639,0.06710333],"study_design_scores_gemma":[0.47178313,0.27262944,0.06845101,0.0013892769,0.12559022,0.00038548486,0.00044291627,0.019480642,0.010749385,0.009322727,0.019473258,0.0003024958],"about_ca_topic_score_codex":0.00076253543,"about_ca_topic_score_gemma":0.0009839189,"teacher_disagreement_score":0.017897671,"about_ca_system_score_codex":0.0011204851,"about_ca_system_score_gemma":0.0010959562,"threshold_uncertainty_score":0.09465301},"labels":[],"label_agreement":null},{"id":"W4220995900","doi":"10.1186/s40164-022-00272-3","title":"Trends in platelet count among cancer patients","year":2022,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Platelet; Cancer; Internal medicine; Lung cancer; Stomach cancer; Hematology; Incidence (geometry); Gastroenterology; Oncology","score_opus":0.016487234769639578,"score_gpt":0.32386314138243305,"score_spread":0.30737590661279346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220995900","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8432412,0.010066407,0.000587911,0.11970917,0.0017299254,0.000084071005,0.0028274495,0.00010116654,0.021652766],"genre_scores_gemma":[0.9519826,0.0034620152,0.0004874882,0.037419826,0.0027360374,0.00007637308,0.0008909694,0.000012955562,0.0029317113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995097,0.00011854491,0.00006129991,0.000090694026,0.0001467831,0.000073005824],"domain_scores_gemma":[0.9980611,0.0005109687,0.00038071486,0.0000835543,0.00071639026,0.00024720814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046546105,0.00009249167,0.00030257273,0.000593741,0.00044063275,0.0005537144,0.00021328821,0.001172698,0.0006315509],"category_scores_gemma":[0.0033584118,0.000093738214,0.00014420458,0.0010253218,0.00016022743,0.0004266642,0.00013847217,0.0010060554,0.0004299456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044822998,0.000072934454,0.92785615,0.000057129753,0.00004027312,0.0021699227,0.00031672884,0.000104364335,0.0009213266,0.00038461568,0.036921073,0.030707343],"study_design_scores_gemma":[0.000052150386,0.0005111374,0.9495939,0.0001288652,0.00005854709,0.008605713,0.0006994994,0.0013415634,0.000958497,0.0008229809,0.037181575,0.000045633973],"about_ca_topic_score_codex":0.004712837,"about_ca_topic_score_gemma":0.007920287,"teacher_disagreement_score":0.004712837,"about_ca_system_score_codex":0.0008991667,"about_ca_system_score_gemma":0.0003455023,"threshold_uncertainty_score":0.009370863},"labels":[],"label_agreement":null},{"id":"W4295943093","doi":"10.1186/s40164-022-00310-0","title":"Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma","year":2022,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Children's Hospital; University of British Columbia","funders":"Michael Cuccione Foundation; Canadian Institutes of Health Research; Canada Research Chairs; Michael Smith Health Research BC; BC Children's Hospital; Children's Hospital Foundation","keywords":"Bone marrow; Medicine; Interstitial fluid; Haematopoiesis; Extracellular fluid; Pathology; Leukemia; Immunology; Stem cell; Cell biology; Biology; Extracellular","score_opus":0.016777277780627983,"score_gpt":0.29104835976169247,"score_spread":0.2742710819810645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295943093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93371296,0.013844251,0.033653732,0.0006347303,0.00013923323,0.00021527937,0.013618286,0.00048638435,0.0036951797],"genre_scores_gemma":[0.92042047,0.0078437915,0.053039458,0.0009113552,0.00013288921,0.0003340707,0.014204742,0.0002395391,0.0028737118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995053,0.000055488144,0.000033224267,0.00013664819,0.00017819498,0.00009107335],"domain_scores_gemma":[0.99973875,0.000050622457,0.00007467393,0.000021685166,0.00007179836,0.000042469397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041737544,0.00051477354,0.0006633315,0.0021642344,0.0004571649,0.0015038212,0.00023920857,0.00059889135,0.00087089883],"category_scores_gemma":[0.00047978817,0.00017890426,0.00064279785,0.0014882975,0.00040632515,0.00048134223,0.00092858175,0.0007432817,0.0005123265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031090353,0.000053647254,0.017225718,0.00036500802,0.00010484997,0.0002815444,0.00015742924,0.00020771999,0.96827435,0.00018303242,0.0003762821,0.01245953],"study_design_scores_gemma":[0.0000367486,0.0007029024,0.56584126,0.00022701589,0.00054764544,0.002982264,0.001298614,0.0067003807,0.39033046,0.0014088991,0.029804643,0.00011924272],"about_ca_topic_score_codex":0.0008046945,"about_ca_topic_score_gemma":0.0012968489,"teacher_disagreement_score":0.0021642344,"about_ca_system_score_codex":0.0002688622,"about_ca_system_score_gemma":0.0003790256,"threshold_uncertainty_score":0.002913475},"labels":[],"label_agreement":null},{"id":"W4308522406","doi":"10.1186/s40164-022-00339-1","title":"Pan-cancer landscape of aberrant DNA Methylation across childhood Cancers: Molecular Characteristics and Clinical relevance","year":2022,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Genome British Columbia; University of British Columbia","funders":"Southern Methodist University","keywords":"dNaM; DNA methylation; Cancer; Epigenetics; Medicine; Carcinogenesis; Methylation; CpG site; Oncology; Cancer research; Internal medicine; Bioinformatics; Biology; Genetics; Gene; Gene expression","score_opus":0.01870720497526948,"score_gpt":0.35887694917859453,"score_spread":0.340169744203325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308522406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377316,0.002398719,0.0015702748,0.00006149205,0.000004589969,0.000015792766,0.0013108955,0.000044478747,0.00082058785],"genre_scores_gemma":[0.9970266,0.0006229235,0.0011797742,0.000023238123,0.0000058162664,0.000009864482,0.00094662514,0.000011914598,0.00017316149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997234,0.000036393547,0.000024044848,0.00010882548,0.000045960318,0.00006135267],"domain_scores_gemma":[0.9995009,0.00011529334,0.00019529356,0.000051764076,0.00006634847,0.00007038954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035524144,0.00020150309,0.00034398158,0.00087025505,0.00029035925,0.00040813102,0.00017766652,0.00019349543,0.0012035662],"category_scores_gemma":[0.0007572208,0.00014583615,0.00019770971,0.0011664529,0.0002517022,0.00021712211,0.00042960633,0.0003110574,0.0001305977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025955337,0.0000096697695,0.950259,0.00007824611,0.0000938154,0.0002345733,0.00014259918,0.00018130947,0.031294633,0.00010711245,0.00020093376,0.017138556],"study_design_scores_gemma":[0.000004063565,0.0000589985,0.9915752,0.0000073339684,0.000075587355,0.0017701779,0.00015973071,0.00034485833,0.004583374,0.00009395603,0.0013229583,0.0000038068956],"about_ca_topic_score_codex":0.003235468,"about_ca_topic_score_gemma":0.0066762986,"teacher_disagreement_score":0.003235468,"about_ca_system_score_codex":0.00031995922,"about_ca_system_score_gemma":0.0003019313,"threshold_uncertainty_score":0.0064332485},"labels":[],"label_agreement":null},{"id":"W4318316239","doi":"10.1186/s40164-023-00375-5","title":"Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cytotoxic T cell; CD8; Immunology; Perforin; Chronic lymphocytic leukemia; TIGIT; Interleukin 21; T cell; Granzyme B; Cytokine; Biology; Cancer research; Medicine; Immune system; Leukemia","score_opus":0.013369603422608392,"score_gpt":0.27885258195266605,"score_spread":0.26548297853005765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318316239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855024,0.0006931255,0.00032101184,0.000013261524,0.0000028886977,0.0000073665933,0.00009940349,0.00001272469,0.00030001032],"genre_scores_gemma":[0.9988354,0.0002524631,0.00022407278,0.000025016287,0.0000063877515,0.000018553013,0.00018681496,0.000004109813,0.00044715492],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999007,0.000020476935,0.00000901528,0.000026583486,0.000014729051,0.000028441882],"domain_scores_gemma":[0.99992406,0.000013057226,0.000023395976,0.000009183534,0.000007429297,0.000022954577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011241897,0.00017513582,0.00014712464,0.0003693619,0.00013718671,0.00016882282,0.000090787595,0.00013768837,0.0017090264],"category_scores_gemma":[0.000099760175,0.000091646725,0.00009277415,0.00019595494,0.00015752757,0.000099375735,0.00016569006,0.00014742544,0.00022813096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010758146,0.00008205408,0.01957884,0.00007866097,0.00000930944,0.00017847365,0.000048441514,0.00006811332,0.9724865,0.000053441752,0.00009535858,0.0062450254],"study_design_scores_gemma":[0.00023669723,0.0049032676,0.57255566,0.000052523068,0.00012434219,0.007153444,0.0003637908,0.0025093239,0.40131888,0.00028935663,0.010473214,0.00001949492],"about_ca_topic_score_codex":0.0004120786,"about_ca_topic_score_gemma":0.00044355725,"teacher_disagreement_score":0.0017090264,"about_ca_system_score_codex":0.0001598572,"about_ca_system_score_gemma":0.00007642276,"threshold_uncertainty_score":0.005717218},"labels":[],"label_agreement":null},{"id":"W4390912419","doi":"10.1186/s40164-024-00473-y","title":"Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy","year":2024,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Hematology; Lymphoma; Transplantation; Refractory (planetary science); Surgery; Oncology","score_opus":0.018795935414203605,"score_gpt":0.3165809880801099,"score_spread":0.2977850526659063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390912419","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979481,0.00046273723,0.00009058689,0.000118745804,0.000014822113,0.000009157017,0.00018671934,0.000004844045,0.0011641945],"genre_scores_gemma":[0.9986369,0.0002299217,0.00006205716,0.00011196836,0.00006253243,0.000009560229,0.0005848735,0.0000037678774,0.00029845815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996754,0.0000648874,0.000055958204,0.00004112083,0.00005801107,0.00010456901],"domain_scores_gemma":[0.9991947,0.00017602192,0.0003158764,0.000036019093,0.00006285671,0.00021445769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257118,0.00018775607,0.00029652848,0.00059757056,0.00048297376,0.00055556785,0.00017628919,0.00040531735,0.00082864356],"category_scores_gemma":[0.0010906616,0.000111468304,0.00024774327,0.00061965553,0.00027761643,0.0002681168,0.00032917905,0.00033322824,0.00030502595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007778043,0.00010125463,0.9643771,0.000024994515,0.000039325678,0.0222358,0.00013950316,0.00024431018,0.0008572059,0.00006970939,0.00068439136,0.010448714],"study_design_scores_gemma":[0.00010341515,0.0013602088,0.8859026,0.000028928953,0.00008596219,0.106521875,0.00043013037,0.0010751347,0.0010563396,0.0002542527,0.0031572466,0.000023919742],"about_ca_topic_score_codex":0.000690031,"about_ca_topic_score_gemma":0.0010089639,"teacher_disagreement_score":0.00082864356,"about_ca_system_score_codex":0.00048592224,"about_ca_system_score_gemma":0.00028975366,"threshold_uncertainty_score":0.0035256743},"labels":[],"label_agreement":null},{"id":"W4401529334","doi":"10.1186/s40164-024-00550-2","title":"M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis","year":2024,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Cancer research; Cancer stem cell; Metastasis; Tumor-associated macrophage; CD44; CCR2; Biology; Tumor microenvironment; Chemokine; Epithelial–mesenchymal transition; CCL5; CCL2; Cancer; Chemokine receptor; Stem cell; Immune system; Immunology; Cell; T cell; Cell biology; IL-2 receptor","score_opus":0.01659646511234917,"score_gpt":0.30931182019321296,"score_spread":0.29271535508086377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401529334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963586,0.0018681934,0.00073183264,0.0001007536,0.000014381458,0.000023322784,0.00014669744,0.000035675843,0.0007204922],"genre_scores_gemma":[0.9978503,0.00060512655,0.0005776433,0.00004290996,0.000012638806,0.00002695777,0.00017818331,0.000005525499,0.00070079387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998802,0.000029232564,0.000010378973,0.00001757067,0.000021482954,0.00004121116],"domain_scores_gemma":[0.99987984,0.000010503896,0.000042102383,0.000011169999,0.000017620754,0.000038742615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002023263,0.0002860528,0.00018920744,0.00039219297,0.00020672461,0.00035742167,0.000102616796,0.00024666355,0.0015030596],"category_scores_gemma":[0.00019293831,0.00011210906,0.00029638235,0.00023963292,0.0002305876,0.00022445638,0.00031145415,0.00026089814,0.00029726812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090056576,0.00009558903,0.017728347,0.00028675437,0.000023896548,0.0006064098,0.00009904712,0.00014872676,0.97545415,0.00022677475,0.00033706965,0.0040925127],"study_design_scores_gemma":[0.0003341615,0.0024746426,0.23224613,0.00008959044,0.00020265908,0.0044923564,0.0010379347,0.004259531,0.7370677,0.0005717862,0.01718557,0.000037923586],"about_ca_topic_score_codex":0.00038517726,"about_ca_topic_score_gemma":0.0005861614,"teacher_disagreement_score":0.0015030596,"about_ca_system_score_codex":0.00026833417,"about_ca_system_score_gemma":0.0003564466,"threshold_uncertainty_score":0.005028188},"labels":[],"label_agreement":null},{"id":"W4401955747","doi":"10.1186/s40164-024-00558-8","title":"Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment","year":2024,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Zhejiang Province; Cornell Center for Materials Research; Research and Innovation Foundation; University of Hong Kong; National Natural Science Foundation of China; University of Ottawa; Health and Medical Research Fund; Impact Fund","keywords":"RHOA; Polyunsaturated fatty acid; Tumor microenvironment; Chemistry; YAP1; Cell biology; Cancer research; Cancer; Internal medicine; Signal transduction; Biochemistry; Biology; Medicine; Gene; Fatty acid; Transcription factor","score_opus":0.010716895562758186,"score_gpt":0.28856084481375693,"score_spread":0.27784394925099876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401955747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018735,0.0043974523,0.0027178146,0.00029702144,0.00007998173,0.000038953975,0.0008310831,0.000091891765,0.0013583461],"genre_scores_gemma":[0.99406105,0.0019164935,0.0012548052,0.00013244005,0.000019138624,0.00008276812,0.0004826372,0.000019814739,0.0020307375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999187,0.000012532491,0.000007997201,0.000017678753,0.000013321786,0.000029739738],"domain_scores_gemma":[0.99994314,0.0000054498196,0.00001784798,0.0000047430567,0.0000103005195,0.000018552788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011563021,0.00024850524,0.00020150443,0.0002173906,0.00015498238,0.00020886319,0.00010526091,0.00019813074,0.0020235886],"category_scores_gemma":[0.000080382495,0.000105056446,0.0002826268,0.00012647542,0.00017760132,0.00021447387,0.0002594542,0.00056717865,0.00028426334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060331693,0.00005087051,0.00068380474,0.00020885051,0.000012653509,0.0000705729,0.000026839924,0.000062411484,0.99569726,0.0001146834,0.00017826424,0.0022904156],"study_design_scores_gemma":[0.00010931775,0.0009960025,0.016961042,0.00004549096,0.00007856716,0.00023386777,0.00023430177,0.0016490173,0.9709952,0.00028055703,0.008405707,0.000010982764],"about_ca_topic_score_codex":0.0003704085,"about_ca_topic_score_gemma":0.0007203323,"teacher_disagreement_score":0.0020235886,"about_ca_system_score_codex":0.00015207753,"about_ca_system_score_gemma":0.00021210872,"threshold_uncertainty_score":0.006769538},"labels":[],"label_agreement":null},{"id":"W4408157999","doi":"10.1186/s40164-025-00610-1","title":"Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Oncology; Follicular phase; Internal medicine; Lymphoma; Second line; First line; Biology","score_opus":0.051390398366162875,"score_gpt":0.39864506947045025,"score_spread":0.34725467110428737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408157999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97935677,0.00579445,0.0048337216,0.00024402524,0.00048737394,0.0024491039,0.003176361,0.000102354374,0.0035557495],"genre_scores_gemma":[0.99350774,0.00040272012,0.0026436055,0.00023288332,0.000083644016,0.0013605363,0.0010533029,0.000012941399,0.0007025999],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9878478,0.008859296,0.000821053,0.0010513371,0.0009335185,0.00048703246],"domain_scores_gemma":[0.99017817,0.005305563,0.002440196,0.0012008821,0.00043987163,0.0004352236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011143614,0.0013229362,0.0024861677,0.000756007,0.00027413457,0.00096244353,0.0012364791,0.0010899703,0.0070380396],"category_scores_gemma":[0.015628632,0.00042898286,0.005833757,0.00051951007,0.00083788834,0.0009170321,0.0011958446,0.0020578376,0.0004480552],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8988897,0.0021464336,0.014855198,0.0017215709,0.037792135,0.000051877334,0.00011483581,0.0039903186,0.002405136,0.0011077618,0.0010809345,0.03584409],"study_design_scores_gemma":[0.37268767,0.36206287,0.1120338,0.00050321606,0.095383056,0.000443091,0.0002708791,0.029080631,0.010385323,0.006173573,0.010735894,0.00024008322],"about_ca_topic_score_codex":0.0009795784,"about_ca_topic_score_gemma":0.0010387573,"teacher_disagreement_score":0.011143614,"about_ca_system_score_codex":0.0012347185,"about_ca_system_score_gemma":0.0010077006,"threshold_uncertainty_score":0.058933735},"labels":[],"label_agreement":null},{"id":"W4410043874","doi":"10.1186/s40164-025-00630-x","title":"IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway","year":2025,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Fonds de recherche du Québec; McGill University Health Centre; McGill University","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Metastasis; Cancer; Malignant transformation; Medicine; STAT3; Signal transduction; Cytokine; Cell; Biology; Head and neck cancer; Immunology; Internal medicine; Cell biology","score_opus":0.00991955200636968,"score_gpt":0.2768775731230813,"score_spread":0.26695802111671163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410043874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655354,0.0008069169,0.0012523043,0.00009451081,0.000016216256,0.000019598107,0.0003362473,0.000049544426,0.0008710885],"genre_scores_gemma":[0.9971097,0.00040985286,0.00087273825,0.000026446383,0.0000040331515,0.000022765747,0.000473967,0.0000056314475,0.0010749354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998909,0.000013403495,0.000011550536,0.000020932242,0.000043055235,0.000020104419],"domain_scores_gemma":[0.99990773,0.000009998956,0.000034741686,0.000013728637,0.000012276906,0.000021533597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010424732,0.00018405147,0.00018144697,0.00015772806,0.00014623329,0.00025086344,0.000108316955,0.0001859348,0.0016661555],"category_scores_gemma":[0.00008716821,0.00007921445,0.0002572695,0.0001337058,0.00019535836,0.00015185367,0.0001613646,0.00042930178,0.00044104096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098542354,0.000025954712,0.00055739866,0.000030135141,0.0000033983156,0.00006226218,0.0000107758115,0.000020720547,0.9985183,0.00004256181,0.000031798198,0.00059813436],"study_design_scores_gemma":[0.000018159466,0.0002515288,0.0146946795,0.000006447512,0.000014744167,0.0005003667,0.00006174339,0.0005919827,0.9821169,0.000043577256,0.001696981,0.0000030010924],"about_ca_topic_score_codex":0.00022955246,"about_ca_topic_score_gemma":0.00035515902,"teacher_disagreement_score":0.0016661555,"about_ca_system_score_codex":0.00022598705,"about_ca_system_score_gemma":0.00014057178,"threshold_uncertainty_score":0.0055738688},"labels":[],"label_agreement":null},{"id":"W4410464105","doi":"10.1186/s40164-025-00662-3","title":"Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines","year":2025,"lang":"en","type":"review","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National University Health System","keywords":"Cancer immunotherapy; Medicine; Cancer; Immunotherapy; Blood cancer; Immunology; Oncology; Internal medicine","score_opus":0.27417381271174723,"score_gpt":0.4431416177267477,"score_spread":0.16896780501500047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410464105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018503707,0.9539702,0.017373001,0.0034522773,0.00061014347,0.00008784303,0.00005674586,0.00010169534,0.0058445246],"genre_scores_gemma":[0.11702441,0.8599282,0.014636317,0.0028444144,0.000803966,0.00018433185,0.00014165882,0.00004365324,0.004393153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997739,0.00006624007,0.000011822029,0.00003895925,0.000056171342,0.00005293367],"domain_scores_gemma":[0.999892,0.000049838804,0.000014217271,0.000005407622,0.000019763418,0.000018774837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083498965,0.0004560011,0.0006408201,0.00083529,0.00018407553,0.0010644266,0.00044879984,0.0009084677,0.0018264524],"category_scores_gemma":[0.00041312742,0.00022013739,0.0007460887,0.00040568088,0.0004990813,0.002101514,0.00068752246,0.0015732528,0.0006022373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000499541,0.000651396,0.0007964849,0.0065869372,0.00019436766,0.0007116592,0.0002627305,0.004331126,0.12482488,0.048749175,0.011845123,0.8005466],"study_design_scores_gemma":[0.00032171677,0.004147926,0.002012211,0.0020298446,0.00039148278,0.003913219,0.00030838925,0.010494017,0.12841983,0.03194693,0.81590205,0.00011240637],"about_ca_topic_score_codex":0.00042904034,"about_ca_topic_score_gemma":0.00067219394,"teacher_disagreement_score":0.0018264524,"about_ca_system_score_codex":0.0007393774,"about_ca_system_score_gemma":0.0006033168,"threshold_uncertainty_score":0.0061101317},"labels":[],"label_agreement":null},{"id":"W4410923614","doi":"10.1186/s40164-025-00671-2","title":"Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway","year":2025,"lang":"en","type":"erratum","venue":"Experimental Hematology and Oncology","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Cancer research; Alpha (finance); Antioxidant; Basal cell; STAT3; Receptor; Chemistry; Signal transduction; Cell biology; Biology; Internal medicine; Medicine; Biochemistry","score_opus":0.005733744149326284,"score_gpt":0.2424525232188258,"score_spread":0.2367187790694995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410923614","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035069152,0.0010719617,0.0006458009,0.025196258,0.969999,0.000018104456,0.0006211759,0.0002451593,0.0018518129],"genre_scores_gemma":[0.030110648,0.011557916,0.008349772,0.0571404,0.43531418,0.00022477776,0.0030897544,0.0016318252,0.4525808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845505,0.00021408896,0.00027003282,0.00021821323,0.0006917793,0.00015078562],"domain_scores_gemma":[0.9911548,0.0019360106,0.00062146905,0.00061480975,0.0049210447,0.00075179327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019522086,0.0019528368,0.0015535954,0.0025048053,0.0018394907,0.0020578024,0.0026486549,0.005248833,0.03403873],"category_scores_gemma":[0.019116163,0.00092308957,0.0012994478,0.0013483565,0.0015717847,0.0014928217,0.0012283921,0.00811864,0.019303175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009888225,0.000015932463,0.00012798632,0.00022880879,0.000025904506,0.0011744238,0.000030133408,0.00008145849,0.00033428523,0.0006999242,0.98863983,0.008542453],"study_design_scores_gemma":[0.00006625458,0.000030215586,0.0012936716,0.00020407885,0.00007466158,0.001995471,0.0000671877,0.00037889456,0.0015610246,0.00090483733,0.99338585,0.000037900856],"about_ca_topic_score_codex":0.008645592,"about_ca_topic_score_gemma":0.010528758,"teacher_disagreement_score":0.03403873,"about_ca_system_score_codex":0.0026250128,"about_ca_system_score_gemma":0.002362447,"threshold_uncertainty_score":0.11387086},"labels":[],"label_agreement":null}]}